McDonald’s Corporation (MCD) had a light trading with around 3.01M shares changing hands compared to its three month average trading volume of 3.69M. The stock traded between $126.31 and $127.82 before closing at the price of $126.7 with 0.17% change on the day. The Oak Brook Illinois 60523 based company is currently trading 15.73% above its 52 week low of $110.33 and -1.77% below its 52 week high of $131.96. Both the RSI indicator and target price of 71.68 and $131.17 respectively, lead us to believe that it could drop over the coming weeks.
McDonald’s Corporation operates and franchises McDonald’s restaurants in the United States, Europe, the Asia/Pacific, the Middle East, Africa, Canada, and Latin America. The company’s restaurants offer various food products, soft drinks, coffee, and other beverages. As of December 31, 2015, it operated 36,525 restaurants, including 30,081 franchised restaurants comprising 21,147 franchised to conventional franchisees, 5,529 licensed to developmental licensees, and 3,405 licensed to foreign affiliates; and 6,444 company-operated restaurants. The company has strategic partnerships with CITIC Limited, CITIC Capital, and The Carlyle Group to expand its business in Mainland China and Hong Kong. McDonald’s Corporation was founded in 1940 and is based in Oak Brook, Illinois.
The Hartford Financial Services Group, Inc. (HIG) managed to rebound with the stock declining 0% or $0 to close the day at $48.6 on active trading volume of 3M shares, compared to its three month average trading volume of 2.5M. The Hartford Connecticut 06155 based company has been outperforming the property & casualty insurance group over the past 52 weeks, with the stock gaining 18.65%, compared to the industry which has advanced 27.04% over the same period. With RSI of 56.97, the stock should still continue to rise and get closer to its one year target estimate of $52.42, making it a hold for now.
The Hartford Financial Services Group, Inc., through its subsidiaries, provides insurance and financial services to individual and business customers in the United States. It operates through six segments: Commercial Lines, Personal Lines, Property & Casualty Other Operations, Group Benefits, Mutual Funds, and Talcott Resolution. The Commercial Lines segment offers workers’ compensation, property, automobile, liability, umbrella, marine, and livestock insurance, as well as customized insurance products and services, including general liability, professional liability, bond, and specialty casualty coverages. The Personal Lines segment provides automobile, homeowners, and personal umbrella coverages to individuals. The Property & Casualty Other Operations segment manages property and casualty insurance. The Group Benefits segment offers group life, accident and disability coverage, and group retiree health to employer groups, associations, and affinity groups; and disability underwriting, administration, claims processing, and reinsurance to other insurers and self-funded employer plans. The Mutual Funds segment provides investment products for retail and retirement accounts; and investment-management and administrative services, such as product design, implementation, and oversight, as well as the runoff of the mutual funds supporting the company’s variable annuity products. The Talcott Resolution segment engages in the U.S. annuity, institutional, and private-placement life insurance businesses. It has a research partnership with UCLA Anderson Forecast to understand the critical economic issue and other trends affecting small business. The Hartford Financial Services Group, Inc. was founded in 1810 and is headquartered in Hartford, Connecticut.
Allergan plc (AGN) shares were down in last trading by -0.96% to $246.93. It experienced lighter than average volume on day. The stock increased in value by almost 0.51% over the past week and grew 14.02% in the past month. It is currently trading 15.82% above its 50 day moving average and 8.92% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -18.05% decrease in value from its one year high of $301.32. The RSI indicator value of 78.81, lead us to believe that it may reverse gains in the near term.
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women’s health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer’s disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians’ offices. Further, the company develops, processes, and markets tissue-based products for use in reconstructive, orthopedic, and urogynecologic surgical procedures to repair soft tissue defects. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.